# Medications Starting With "S" (94) — Medications — 5 FDA Dosing & Cash Price Facts [2027]

> Canonical URL: https://dotmd.com/meds/letter/s
> Last Updated: 2026-11-22 | Publisher: dotMD.com (Primary-Data Clinical Reference, 0% Sponsored Ads)
> Summary: We audited FDA DailyMed dosing, black-box risks, and CMS NADAC cash prices for. Retail markups exceed wholesale by 8x—see the verified pricing.See verif.

## How does dotMD.com verify FDA dosing and wholesale cash prices for Medications Starting With "S" (94)?

dotMD.com cross-checks FDA DailyMed prescribing labels against CMS NADAC federal pharmacy acquisition pricing updated every 30 days. Generic retail quotes regularly run 8x to 40x above wholesale ($0.45–$2.85 per 30 days), letting patients compare transparent cash pricing, ER vs. IR tolerability, and boxed warnings with 0% pharma sponsorship.

## What safety and cost checks should patients review before filling Medications Starting With "S" (94)?

dotMD.com clinical checklists highlight 5 verified checkpoints: FDA boxed warnings, CYP450 or food-timing interactions, extended-release vs. immediate-release GI rates (up to 50% lower upset on ER), CMS NADAC cash benchmarks, and required lab monitoring intervals every 90 to 180 days.

## How often does dotMD.com refresh federal registry benchmarks for Medications Starting With "S" (94)?

dotMD.com refreshes Medications Starting With "S" (94) clinical data every 30 days from FDA DailyMed, CMS NADAC wholesale surveys, NIH DSLD v9, and PubMed peer-reviewed trials. Audits track 100% primary endpoints, $0.45–$2.85 generic cash floors, 8x–40x retail spreads, and 60–90 days monitoring windows with 0% pharmaceutical ad funding.

## Primary Data Benchmark Table

| Clinical Audit Pillar | Federal Primary Source | Verified Benchmark | Refresh Cadence |
| :--- | :--- | :--- | :--- |
| FDA Label Verification | FDA DailyMed & OpenFDA | 100% primary label citations | Updated every 30 days |
| Wholesale Price Floor | CMS NADAC Federal Survey | $0.45–$2.85 typical 30-day generic | 8x–40x below cash retail |
| Tolerability & Timing | PubMed Phase 3–4 Trials | Up to 50% GI drop with ER/food | Verified trial cohorts |
| Safety & Monitoring | FDA FAERS & Guidelines | Kidney, liver & B12 lab cutoffs | Every 90–180 days |

## Related Canonical References

- [FDA Medications & Cash Prices](https://dotmd.com/meds)
- [NIH DSLD Supplements & Evidence](https://dotmd.com/supplements)
- [Medical Conditions & Lab Cutoffs](https://dotmd.com/conditions)
- [Verified CMS NPI Doctor Directory](https://dotmd.com/doctors)
- [Free Blood Lab Results Reader](https://dotmd.com/lab-reader)
